Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes

被引：92
|
作者：
Li, W. [1 ,5 ]
Liu, Y. [1 ]
He, Y. -Q. [2 ]
Zhang, J. -W. [1 ]
Gao, Y. [3 ]
Ge, G. -B. [1 ,5 ]
Liu, H. -X. [1 ,5 ]
Huo, H. [1 ]
Liu, H. -T. [1 ,5 ]
Wang, L. -M. [3 ]
Sun, J. [3 ]
Wang, Q. [4 ]
Yang, L. [1 ]
机构：
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China
[3] Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China
[4] Dalian Univ Technol, Dalian, Peoples R China
[5] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China
来源：
XENOBIOTICA | 2008年 / 38卷 / 12期
基金：
中国国家自然科学基金;
关键词：
Triptolide; cytochrome P450; mono-hydroxylated metabolite;
D O I：
10.1080/00498250802503359
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Triptolide, the primary active component of a traditional Chinese medicine Tripterygium wilfordii Hook F, has a wide range of pharmacological activities. In the present study, the metabolism of triptolide by cytochrome P450s was investigated in human and rat liver microsomes. Triptolide was converted to four metabolites (M-1, M-2, M-3, and M-4) in rat liver microsomes and three (M-2, M-3, and M-4) in human liver microsomes. All the products were identified as mono-hydroxylated triptolides by liquid chromatography-mass spectrometry (LC-MS). The studies with chemical selective inhibitors, complementary DNA-expressed human cytochrome P450s, correlation analysis, and enzyme kinetics were also conducted. The results demonstrate that CYP3A4 and CYP2C19 could be involved in the metabolism of triptolide in human liver, and that CYP3A4 was the primary isoform responsible for its hydroxylation.
引用
收藏
页码：1551 / 1565
页数：15
相关论文
共 50 条
  • [21] Modeling the hydroxylation of estragole via human liver cytochrome P450
    Yadav, Rolly
    Awasthi, Nidhi
    Shukla, Anamika
    Kumar, Devesh
    JOURNAL OF MOLECULAR MODELING, 2021, 27 (07)
  • [22] Effect of γ-oryzanol on cytochrome p450 activities in human liver microsomes
    Umehara, K
    Shimokawa, Y
    Miyamoto, G
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (07) : 1151 - 1153
  • [23] Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes
    Albassam, Ahmed A.
    Ahad, Abdul
    Alsultan, Abdullah
    Al-Jenoobi, Fahad I.
    SAUDI PHARMACEUTICAL JOURNAL, 2018, 26 (05) : 673 - 677
  • [24] Effect of probucol on cytochrome P450 activities in human liver microsomes
    Umehara, K
    Shimokawa, Y
    Miyamoto, G
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (08) : 1112 - 1114
  • [25] Hydroxylation of Tanshinone IIa in Human Liver Microsomes Is Specifically Catalyzed by Cytochrome P450 2A6
    Liu, Hui-Xin
    Hu, Ying
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2009, 41 : 31 - 31
  • [26] The metabolism of genistein by rat liver microsomes and recombinant human cytochrome P450 enzymes.
    Roberts-Kirchhoff, ES
    Crowley, JR
    Hollenberg, PF
    Kim, H
    FASEB JOURNAL, 1998, 12 (08): : A1425 - A1425
  • [27] Relationship between the metabolism of neferine in rat liver microsomes and cytochrome P450
    Jiang, Min
    Xiong, Yu-qing
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 207 - 208
  • [28] Effect of Bakumondo-to on cytochrome P450 activities in rat liver microsomes
    Yasuhara, Masako
    Tayama, Yoshitaka
    Kashiwagi, Takehiro
    Sawa, Akihiro
    Kihira, Kenji
    Miyake, Katsushi
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2016, 28 (02) : 198 - 202
  • [29] STUDIES OF MULTIPLE CYTOCHROME P450 HEMOPROTEINS IN RAT-LIVER MICROSOMES
    WELTON, AF
    MANDORF, LC
    AUST, SD
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1437 - 1437
  • [30] TOLBUTAMIDE HYDROXYLATION BY HUMAN, RABBIT AND RAT-LIVER MICROSOMES AND BY PURIFIED FORMS OF CYTOCHROME-P-450
    VERONESE, ME
    MCMANUS, ME
    LAUPATTARAKASEM, P
    MINERS, JO
    BIRKETT, DJ
    DRUG METABOLISM AND DISPOSITION, 1990, 18 (03) : 356 - 361
12345